Soaring insulin prices
Oct 30 | Sarah Jane Tribble, Kaiser Health News
Attorneys general in Washington, Minnesota and New Mexico issued civil investigative demands about…
Petya cyberattack cost Merck $135 million
Oct 27 | Jessica Davis
Third-quarter revenue for the global pharma giant was drastically reduced in part by the temporary production shutdown, higher demand…
Oct 27 | Susan Morse
Amazon's potential foray into pharmacy business could squeeze providers' bottom lines…
Supervising pharmacist convicted in deadly meningitis outbreak
Oct 26 | Beth Jones Sanborn
Prosecutors said 76 people died, more than 750 sickened from tainted injections after…
Trump declares opioid epidemic a public health emergency
Oct 26 | Susan Morse
Announcement falls short of national emergency status which would have triggered release of federal funds.
Biosimilars can cut health spending
Oct 23 | Jeff Lagasse
Biologics are the fastest-growing segment of prescription drug spending, RAND Corp. says.
Rurals want CMS to pull proposal over drug payments
Oct 20 | Jeff Lagasse
Rule would cut Medicare Part B drug payments to hospitals participating in the 340B drug discount program.
Anthem starts its own PMB
Oct 20 | Susan Morse
Anthem, CVS Health sign 5-year deal for new pharmacy benefits manager, IngenioRx, dealing a blow to Express Scripts.
Oct 17 | Bernie Monegain
EHR maker and pharmacy, which already work together on patient care, will share data and direct patients to lower-priced…
Oct 17 | Liz Szabo, Kaiser Health News
Total costs of Kymriah and 21 similar drugs in development - CAR T-cell therapies - will reach $1 million or more per…